IMANs
Advanced Cervical Cancer, Advanced Head & Neck Cancers
Phase 1Active
Key Facts
Indication
Advanced Cervical Cancer, Advanced Head & Neck Cancers
Phase
Phase 1
Status
Active
Company
About LIfT BioSciences
LIfT BioSciences is developing a unique allogeneic cell therapy platform based on neutrophils, aiming to overcome the limitations of current immunotherapies in treating solid tumours. The company is preparing for its first-in-human Phase 1 clinical trial in advanced cervical and head & neck cancers, supported by significant non-dilutive funding. With a growing international footprint in the UK, Ireland, and the US, and strategic partnerships with entities like Bayer, LIfT is positioning itself to advance its neutrophil-based therapies through clinical development.
View full company profile